SARS-CoV-2 assay for BD Veritor Plus System to be available in Europe by end of October
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced on Wednesday that its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor Plus System has been CE marked to the IVD Directive (98/79/EC). The new test delivers results in 15 minutes on an easy-to-use, portable instrument, which is a critical improvement in turnaround
